Lexicon Pharmaceuticals | LXRX - Marktkapitalisierung

Aktienkurs
1.67
Täglich Wechseln
0.03 1.83%
Monatlich
11.33%
Jährlich
367.66%
Q1 Prognose
1.51




Marktkapitalisierung Veränderung Datum
Abbott USD 217.86B 15.25B 2025-12
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 312M 115M 2026-03
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Coherus Biosciences USD 183M 11M 2026-03
Eli Lilly USD 1.02T 293.84B 2025-12
Esperion Therapeutics USD 475M 410M 2026-03
Halozyme Therapeutics USD 7.91B 664M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Insmed USD 37.12B 6.68B 2025-12
J&J USD 500.24B 67.44B 2025-12
Lexicon Pharmaceuticals USD 416M 2M 2026-03
MacroGenics USD 192M 90M 2026-03
MannKind USD 1.74B 93M 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 240.48B 51.73B 2026-03
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
United Therapeutics USD 20.98B 2.02B 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12